Serum CA19-9 measurement increases the effectiveness of staging laparoscopy in patients with suspected pancreatic malignancy

Digestive Surgery

Volumn 22, Issue 1-2, 2005, Pages 80-85

  Connor, S ^a   Bosonnet, L ^a   Alexakis, N ^a   Raraty, M ^a   Ghaneh, P ^a   Sutton, R ^a   Neoptolemos, J P ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cancer; Computed tomography; Pancreas; Resection; Surgery; Tumour markers

Indexed keywords

BILIRUBIN; CA 19-9 ANTIGEN;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER GRADING; COMPUTER ASSISTED TOMOGRAPHY; DATA BASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE MARKER; HUMAN; INFORMATION RETRIEVAL; JAUNDICE; LAPAROSCOPY; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PANCREAS CARCINOMA; PATIENT SELECTION; PREOPERATIVE CARE;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BILIRUBIN; CA-19-9 ANTIGEN; CARCINOMA, PANCREATIC DUCTAL; CHOLANGIOCARCINOMA; HUMANS; LAPAROSCOPY; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PATIENT SELECTION; SENSITIVITY AND SPECIFICITY;

EID: 19944398471     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085297     Document Type: Article

References (25)

1. Warshaw AI, Gu ZY, Whittenberg J, Waltman AC: Pre-operative staging and assessment of resectability of pancreatic cancer. Arch Surg 1990;125:230-233.
2. Friess H, Kleef J, Silva JC, Sadowski C, Baer HU, Büchler MW: The role of diagnostic laparoscopy in pancreatic and peri-ampullary malignancies. J Am Coll Surg 1998;186:675-682.
3. Holzman MD, Reintgen KL, Tyler DS, Pappas TN: The role of laparoscopy in the management of suspected pancreatic and peri-ampullary malignancies. J Gastrointest Surg 1997;1: 236-244.
4. Rumstadt B, Schwab M, Schuster K, Hagmiller E, Trede M: The role of laparoscopy in the pre-operative staging of pancreatic carcinoma. J Gastrointest Surg 1997;1:245-250.
5. Saldinger PF, Reilly M, Reynolds K, Raptolpoulos V, Cuttani R, Steer ML: Is CT angiography sufficient for prediction of resectability of peri-ampullary neoplasms? J Gastrointest Surg 2000;4:233-237.
6. Pisters PWT, Lee JE, Vauhey JN, Chamsangavej C, Evans DB. Laparoscopy in the staging of pancreatic cancer. Br J Surg 2001;88:325-337.
7. Doran HE, Bosonnet L, Connor S, Jones L, Garvey C, Hughes M, Campbell F, Hartley M, Ghaneh P, Neoptolemos JP, Sutton R: Laparoscopy and laparoscopic ultrasound in the surgical evaluation of pancreatic and periampullary tumours. Dig Surg 2004;21:305-313.
8. Lavonius MI, Laine S, Salo S, Sonninen P, Ovaska J: Role of laparoscopy and laparoscopic ultrasound in staging of pancreatic tumours. Ann Chir Gynaecol 2001;90:252-255.
9. Menack MJ, Spitz JD, Arregui ME: Staging of pancreatic and ampullary cancers for resectability using laparoscopy with laparoscopic ultrasound. Surg Endosc 2001;15:1129-1134.
10. Maire F, Sauvanet A, Trivin F, Hammel P, O'Toole D, Palazzo L, Vilgrain V, Belghiti J, Ruszniewski P, Levy P: Staging of pancreatic head adenocarcinoma with spiral CT and endoscopic ultrasonography: An indirect evaluation of the usefulness of laparoscopy. Pancreatology 2004;4:436-440.
11. Connor S, Neoptolemos JP: Laparoscopy is still necessary in the assessment of peri-ampullary neoplasia. Pancreatology 2004;4:415-416.
12. John TG, Greig JD, Carter DC, Garden OJ: Carcinoma of the pancreatic head and peri-ampullary lesion. Tumour staging with laparoscopy and laparoscopic ultrasonography. Ann Surg 1995;221:156-164.
13. Minnard EA, Conlon KC, Hoos A, Dougherty EC, Hann LE, Brennan MF: Laparoscopic ultrasound enhances standard laparoscopy in the staging of pancreatic cancer. Ann Surg 1998; 228:182-187.
14. Volkner CM, Drebin JA, Middleton WD, Teefey SA, Linehan DC, Soper NJ, Eagon CJ, Strasberg SM: Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies. Ann Surg 2002;235:1-7.
15. Gattani AM, Mandeli J, Bruckner HW: Tumour markers in patients with pancreatic carcinoma. Cancer 1996;78:57-62.
16. Niederau C, Grendell JH: Diagnosis of pancreatic carcinoma. Imaging techniques and tumor markers. Pancreas 1992;7:66-86.
17. Kim HJ, Kim MH, Myung SJ, Lim BC, Park ET, Yoo KS: A new strategy for the application of CA19-9 in the differentiation of pancreatobiliary cancer: Analysis using receiver operating characteristic curve. Am J Gastroenterol 1999;94:1941-1946.
18. Ritts RE Jr, Nagorney DM, Jacobsen DJ, Talbot RW, Zurawski VR: Comparison of pre-operative serum CA19-9 levels with results of diagnostic imaging modalities in patients undergoing laparotomy for suspected pancreatic and gallbladder disease. Pancreas 1994;9: 708-716.
19. Forsmark CE, Lambiase L, Vogel SB: Diagnosis of pancreatic cancer and predication of unresectability using tumour associated antigen CA19-9. Pancreas 1994;9:731-734.
20. Schlieman MG, Ho SH, Bold RJ: Utility of tumour markers in determining resectability of pancreatic cancer. Arch Surg 2003;138:951-956.
21. Roche CJ, Hughes ML, Garvey CJ, Campbell F, White DA, Jones L, Neoptolemos JP: CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. AJR Am J Roentgenol 2003;180:475-480.
22. Ghaneh P, Magee C, Neoptolemos JP: Pancreatic Cancer; in Williams C (ed): Evidence-Based Oncology. London, BMJ Books, 2003, pp 247-272.
23. McCarthy MJ, Evans J, Sagar G, Neoptolemos JP: Prediction of resectability of pancreatic malignancy by computed tomography. Br J Surg 1998;85:320-325.
24. Tempero MA, Uchida E, Takasaki H: Relationship of CA19-9 and CA50 to lewis antigen in pancreatic cancer. Cancer Res 1987;4: 5501-5503.
25. Itzjowitz S, Kim Y: New carbohydrate tumour markers. Gasteroenterolgy 1986;90:491-494.